The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I hold ITV for the potential of a recovery and re rating and small chance of a takeover. Personally income chasers should be thanked as they prop up under performing stocks like ITV and medium to long term holders should be thsankful to them.
Another decent move forward this morning. The share is underpinned at this price by cash and existing operations and a rising oil price. The potential remains for a massive increase in price if the various projects bear fruition and the market has shaken plenty out and a real buying opportunity remains.
Likewise purchased at 1476 as GSK remains a long term hold with a decent income stream. I also think at these levels a bid is not out of the question despite all the obstacles.
Looks like today will be tough based on overnight fall on Oil.. Really thought RDSB was looking at a good run up to 2500 with the divedend looking very safe losing confidence a little.
Some interesting activity going on here. One to watch imo.
very keen on the prospects here but becoming increasingly worried about Trump and his effect on the market. Promising jobs to the rust belt and general protectionism is sheer lunacy and tax cuts that seem unworkable are going to spook the general market. Finally put some stop losses in place.
ell even got the takeover price correct but not the bidder. Just goes to prove that even a blind squirrel will find the odd nut. Get ready for Bunzl at 2 quid
Not sure there is a resistance level either. The share was oversold but equally may be ahead of the game atm based on a yet to be confirmed improvement in trading and margins. Very strong feeling this company will be taken over whatever.
Strange day with a weak SP when the market was on fire and strong on the pull back. Very interesting.
Looks like daily fluctuations are not so dramatic, other than yesterday. Trading update needed for holders otherwise don't see too much going on atm.
Bought back in again @1.1825 and very hopeful 1.30 will be tested soon. Sales are better, just guessing about the margins!
Always difficult for holders in the period after a decent and sustained increase in the SP. The reality is that Brammer may well be seriously undervalued but the next trading statement will be critical. It remains a potential recovery play, nothing more atm. The way it will work before that is just the same as similar stocks, people sell for various reasons, traders take profits and move to other targets. Strongly suspect holders will be rewarded but it is never going to go in a straight line.
Not hugely significant but Brammer have an outlet there so helpful if the go ahead is given.
Bound to be some profit taking at 1.30 plus. However compelling the story traders will take things up and down. The market in general has a nasty look to it from an upside perspective so no real surprise.